Pharmacogenetic and Germline Prognostic Markers of Lung Cancer
113. Kotsinas A, Evangelou K, Sideridou M, et al: The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Cancer Lett 259:177-85, 2008. 114. Pine SR, Mechanic LE, Ambs S, et al: Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- position statement lung cancer screening using low dose
- pharmacogenetic and germline prognostic markers of lung cancer
- suspected lung cancer not mesothelioma
- purpose of application pharmaceutical benefits scheme
- information sheet best practice management of lung cancer
- lung cancer quality improvement monitoring report 2021
- management of oligometastatic non small cell lung cancer
- australian public assessment report for osimertinib mesilate
- lung cancer
- enterprise use case
Related searches
- lung cancer high blood pressure
- coding lung cancer in remission
- lung cancer in lymph nodes
- lung cancer brain mets survival
- stage 4 lung cancer spread to brain
- advances in lung cancer treatment
- symptoms of lung cancer in women
- early stages of lung cancer signs
- early detection of lung cancer symptoms
- lung cancer and pneumonia
- lung cancer and pneumonia survival
- lung cancer and coughing blood